Search - tctmd.com

Displaying 461 - 480 of 891

Sort: Relevancy | Date

Presentation TCT 2013

Case 4: TAVR with Sapien 3 (St. Paul's Hospital/University of British Columbia, Vancouver, Canada)

Presenter: Marian Hawkey

October 29, 2013

Presentation TCT 2013

An Overview of Patient Risk Stratification in Patients Enrolled in the CoreValve US Extreme Risk Study

Presenter: Thomas Gleason

October 29, 2013

Presentation TCT 2013

A Critical Analysis of Functional Improvement after TAVR in the CoreValve US Extreme Risk Study

Presenter: David Cohen

October 29, 2013

Presentation TCT 2013

Yes! The Multicenter Registry Data Are Compelling

Presenter: Nicolas van Mieghem

October 28, 2013

Presentation TCT 2013

United Kingdom

Presenter: Neil Moat

October 28, 2013

Presentation TCT 2013

The Thubrikar TAVR System

Presenter: Susheel Kodali

October 28, 2013

Presentation TCT 2013

The MyVal TAVR System (India)

Presenter: Juan Granada

October 28, 2013

Presentation TCT 2013

Technology Review and Clinical Results(6)

Presenter: Raj Makkar

October 28, 2013

Presentation TCT 2013

Technology Review and Clinical Results(5)

Presenter: John Webb

October 28, 2013

Presentation TCT 2013

Technology Review and Clinical Results(2)

Presenter: Hendrik Treede

October 28, 2013

Presentation TCT 2013

TAVR Technology: Present and Future

Presenter: Ian Meredith

October 28, 2013

Presentation TCT 2013

TAVR

Presenter: Wilson Szeto

October 28, 2013

Presentation TCT 2013

Setting the Stage: FDA Approval vs. CE Mark

Presenter: Sigmund Silber

October 28, 2013

Presentation TCT 2013

Predictive Factors, Management, and Clinical Outcomes of Coronary Obstruction Following TAVR: Results from a Large Multicenter Registry

Presenter: Henrique Ribeiro

October 28, 2013

Presentation TCT 2013

No! Not Benign but Not a Predictor of Mortality

Presenter: Tamim Nazif

October 28, 2013

Presentation TCT 2013

Newer Generation Devices for Valve Implantation: Differentiating Features

Presenter: Hans Figulla

October 28, 2013

Presentation TCT 2013

My Crystal Ball: Procedural Changes (eg, No Predilatation and Cerebral Protection Devices) Will Reduce Strokes After TAVR in the Future

Presenter: Nicolas van Mieghem

October 28, 2013

Presentation TCT 2013

Meaningful Changes in Endpoint Definitions from VARC 2

Presenter: A. Pieter Kappetein

October 28, 2013

Presentation TCT 2013

Italy

Presenter: Corrado Tamburino

October 28, 2013

Presentation TCT 2013

Editorial Comment: TAVR Patient and Device Selection, Complications and Outcomes

Presenter: Ramon Quesada

October 28, 2013

Advertisement

Case 4: TAVR with Sapien 3 (St. Paul's Hospital/University of British Columbia, Vancouver, Canada)

An Overview of Patient Risk Stratification in Patients Enrolled in the CoreValve US Extreme Risk Study

A Critical Analysis of Functional Improvement after TAVR in the CoreValve US Extreme Risk Study

Yes! The Multicenter Registry Data Are Compelling

United Kingdom

The Thubrikar TAVR System

The MyVal TAVR System (India)

Technology Review and Clinical Results(6)

Technology Review and Clinical Results(5)

Technology Review and Clinical Results(2)

TAVR Technology: Present and Future

TAVR

Setting the Stage: FDA Approval vs. CE Mark

Predictive Factors, Management, and Clinical Outcomes of Coronary Obstruction Following TAVR: Results from a Large Multicenter Registry

No! Not Benign but Not a Predictor of Mortality

Newer Generation Devices for Valve Implantation: Differentiating Features

My Crystal Ball: Procedural Changes (eg, No Predilatation and Cerebral Protection Devices) Will Reduce Strokes After TAVR in the Future

Meaningful Changes in Endpoint Definitions from VARC 2

Italy

Editorial Comment: TAVR Patient and Device Selection, Complications and Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content